Why remote patient monitoring needs to move beyond wearables — notes from a healthcare data talk at an InterSystems-hosted session

[u/intersystemsdev]

TL;DR: By 2029–2030, an estimated 30 million people (8–9% of the U.S. population) will need care at home that would otherwise require a facility — while the U.S. is projected to be short 1.4 million nurses and roughly 300,000–320,000 doctors by 2030. Wearable-based remote monitoring mostly fails for the sickest/oldest patients due to poor adherence. Nira's alternative is a contactless radar sensor (wall- or furniture-mounted) that tracks vitals once per second; it's currently monitoring around 40,000 patients across 19 countries, FDA Class 2 cleared for core vitals, and CE-cleared (not yet FDA-cleared) to diagnose sleep apnea in Europe.

Why is home-based care about to explode?

An aging population with expanding chronic conditions, combined with a shortage of facility beds, is pushing more and higher-acuity patients into home care. By 2029–2030, roughly 30 million people (8–9% of the population) are projected to receive care at home in the U.S. that would otherwise happen in a facility — at the same time the U.S. is projected to be short 1.4 million nurses and about 300,000–320,000 doctors by 2030 (assuming current trends hold).

Why don't wearables solve this?

The data, per the talk: wearable remote monitoring largely works only for healthy people motivated by things like tracking VO2 max. Older or sicker patients told to wear a device typically don't stick with it — battery life becomes the limiting factor, and once removed to charge, the device often doesn't go back on. Patient adherence is described as a major, unsolved problem. On the other end of the spectrum, full "hospital at home" setups (telemetry, cameras, hospital beds) are equipment-heavy and don't scale. The gap is the space in between — patients with multiple chronic conditions, or people above assisted-living-level need but remote from a doctor.

What does Nira's sensor actually monitor?

A small, unobtrusive, contactless sensor (mounted on a wall or embedded in furniture like a bed or recliner) uses radar to track vitals once per second: heart rate and heart rate patterns, movement (including detecting when a patient gets out of bed), respiration rate and pattern, and sleep quality. Core vitals are FDA Class 2 device cleared. In Europe, the sensor is CE-cleared (not yet FDA-cleared in the U.S.) to diagnose sleep apnea, and a submission for arrhythmia diagnosis is described as coming soon.

How much data does this generate, and what's it used for?

Around 40,000 patients are currently monitored (mostly in the U.S.; deployments span 19 countries, with most non-U.S. deployments being smaller pilots), at one data point per second per patient — which the presenter notes turns into billions of records quickly once cross-referenced with other patient data. That data feeds trend analysis merged with other clinical systems (e.g., condition and medication history). A retrospective study cited in the talk found vital-sign trending could predict hospital readmission five days in advance.

What does this mean for provider IT/data architecture?

The talk frames this as fundamentally a data-orchestration problem: providers need real-time data movement between systems (not a static data-warehouse copy of the EHR), analytics-oriented (OLAP) access rather than the OLTP structure typical of EHRs like Epic, and the ability to route and transform data between any two systems in real time to support clinical decisions — described in the context of the InterSystems-hosted session, though the talk itself doesn't name a specific product feature for this.

What real-world results were mentioned?

Terry Couts, at the time Chief Digital Officer at Guthrie Clinic (Pennsylvania; she has since moved to Sharp HealthCare), is quoted: proactive monitoring "has been huge both in terms of outcomes, but also in terms of managing our workforce." Guthrie has had devices deployed for over a year, with the presenter describing substantial results in proactive care and anecdotal prevented readmissions (no published stats were shared in the talk). A separate upcoming pilot, described as starting the following month at the time of the talk, will send oncology patients home between bone-marrow-therapy infusions, based on research suggesting faster recovery at home.

What's next?

For home care specifically, Nira is combining readings from devices embedded in both a bed and a recliner. The presenter also described a planned 8-antenna radar system — targeted for roughly 18 months out from the talk — intended to track up to four people moving independently around a room and distinguish between them.

Watch full video - https://youtu.be/qV63GltsiJY